ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0RH1 Kinnevik Ab

341.40
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kinnevik Ab LSE:0RH1 London Ordinary Share SE0015810247 KINNEVIK ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 341.40 334.50 348.30 179,912 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice -4.11B -4.77B -19.5957 -0.55 2.6B

Babylon Closes Business Combination and Will Begin Trading on the New York Stock Exchange Under the Ticker BBLN

21/10/2021 9:30pm

GlobeNewswire Inc.


Kinnevik Ab (LSE:0RH1)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Kinnevik Ab Charts.
Babylon Closes Business Combination and Will Begin Trading on the New York Stock Exchange Under the Ticker BBLN

Kinnevik AB (publ) ("Kinnevik”) today announced that Babylon it has completed its business combination with Alkuri Global Acquisition Corp, a special purpose acquisition company.

The transaction was approved on October 20, 2021 by Alkuri’s shareholders. Babylon’s shares of Class A common stock and its warrants will begin trading on the New York Stock Exchange (“NYSE”) on October 22, 2021 under the new ticker symbols “BBLN” and “BBLN.W”, respectively. After the closing of the transaction, Kinnevik will hold 54,240,640 A shares in the company.

For full information from the company, please see https://www.babylonhealth.com/press/press-room

Georgi Ganev, CEO of Kinnevik commented: “We continue to be impressed by the founder and CEO of Babylon Health, Ali Parsa’s and his team’s dedication to provide affordable, accessible and data-driven healthcare. Babylon Health will now be well capitalized and we welcome new shareholders in the next chapter of its growth journey.”

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations Phone +46 (0)70 762 00 50 Email press@kinnevik.com

Kinnevik’s ambition is to be Europe’s leading listed growth investor, and we back the best digital companies for a reimagined everyday and to deliver significant returns. We understand complex and fast-changing consumer behaviours, and have a strong and expanding portfolio in healthtech, consumer services, foodtech and fintech. As a long-term investor, we strongly believe that investing in sustainable business models and diverse teams will bring the greatest returns for shareholders. We back our companies at every stage of their journey and invest in Europe, with a focus on the Nordics, and in the US. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Attachment

  • Press release pdf

1 Year Kinnevik Ab Chart

1 Year Kinnevik Ab Chart

1 Month Kinnevik Ab Chart

1 Month Kinnevik Ab Chart

Your Recent History

Delayed Upgrade Clock